VVUS

VIVUS, Inc. News Headlines

$3.29
*  
0.09
2.81%
Get VVUS Alerts
*Delayed - data as of Dec. 18, 2014 13:07 ET  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VVUS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Will Belviq Advertising Pick Up Again?
11/6/2014 8:55:00 AM - Seeking Alpha


ADMA To Be Uplisted, VVUS Up After-Hours, NVAX For The Long Haul, CCXI On Watch
11/6/2014 2:04:00 AM - RTT News


Earnings Reaction History: VIVUS, Inc., 80.0% Follow-Through Indicator, 8.2% Sensitive
11/5/2014 3:10:30 PM - MT Newswires


Arena Pharmaceuticals Posts In Line Q3 Loss, Belviq Grows - Analyst Blog
11/4/2014 9:30:00 AM - Zacks.com


Belviq Sales Dip During Holiday Week, Should Show Steady Progress From Here
10/27/2014 7:38:00 AM - Seeking Alpha


Assessing Arena Pharmaceutical Belviq Sales And The Impact Of TV Ads
10/22/2014 9:16:00 AM - Seeking Alpha


Could Arena Pharmaceuticals Inc. Be Running Out of Money?
10/22/2014 7:20:02 AM - Motley Fool


Orexigen Launches Contrave - Watch For Traction
10/20/2014 2:01:00 PM - Seeking Alpha


What To Watch For As Orexigen's Launch Approaches
10/16/2014 8:05:00 AM - Seeking Alpha


Emergent BioSolutions Revamps Business to Drive Earnings - Analyst Blog
10/8/2014 4:50:00 PM - Zacks.com


Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog
10/7/2014 4:40:00 PM - Zacks.com


Regeneron's Eye Drug Eylea Wins Another FDA Approval - Analyst Blog
10/7/2014 3:30:00 PM - Zacks.com


Orexigen On A Tear - In The Wrong Direction
10/7/2014 1:10:00 AM - Seeking Alpha


Is VIVUS Inc. a Short Sell?
10/4/2014 12:45:02 PM - Motley Fool


Premature Combination Use Of Belviq And Phentermine Is A Risk
9/28/2014 9:27:00 AM - Seeking Alpha


Belviq Sales Benefit From Advertising - Up 2.8%
9/26/2014 12:16:00 PM - Seeking Alpha


VIVUS and Auxilium Announce Stendra Label Expansion - Analyst Blog
9/19/2014 5:25:00 PM - Zacks.com


Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect?
9/19/2014 10:50:00 AM - Seeking Alpha


It Takes Less Than 15 Minutes To Buy VVUS Shares!
9/19/2014 8:51:00 AM - Seeking Alpha


VIVUS Inc. (VVUS) Rises: Stock Adds 12.4% in Session - Tale of the Tape
9/19/2014 8:32:00 AM - Zacks.com


NASDAQ Biotech Top Performers (Pre-Open September 19)
9/19/2014 7:30:58 AM - David Krein


Alibaba: An Opportunity Or The Opportunity
9/19/2014 12:40:00 AM - Seeking Alpha


Why VIVUS, Inc. Is Today's Best Biotech Stock
9/18/2014 12:26:33 PM - Motley Fool


Today's Market: Stocks Moving On News, Fed Rally Continues
9/18/2014 10:11:00 AM - Seeking Alpha


Pre-Market Most Active for Sep 18, 2014 : RAD, NOK, VVUS, SAN, MT, NVO, YHOO, AAPL, TKAI, SNE, EMKR, ERIC
9/18/2014 7:39:58 AM - NASDAQ.com News